-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Cancer Capital Corp quarterly/annual Interest Expense history and growth rate from 2013 to 2023.
- Cancer Capital Corp Interest Expense for the quarter ending September 30, 2024 was $2.61K, a 0.04% increase year-over-year.
- Cancer Capital Corp Interest Expense for the twelve months ending September 30, 2024 was $10.4K, a 0.71% increase year-over-year.
- Cancer Capital Corp annual Interest Expense for 2023 was $10.4K, a 7.11% increase from 2022.
- Cancer Capital Corp annual Interest Expense for 2022 was $9.73K, a 32.8% increase from 2021.
- Cancer Capital Corp annual Interest Expense for 2021 was $7.33K, a 9.26% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)